Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts

Abstract Natural killer (NK) cells are a promising allogeneic immunotherapy option due to their natural ability to kill tumor cells, and due to their apparent safety. This study describes the development of a GMP-compliant manufacturing protocol for the local production of functionally potent NK cel...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Farhana Jahan, Leena Penna, Annu Luostarinen, Laurens Veltman, Heidi Hongisto, Kaarina Lähteenmäki, Sabine Müller, Seppo Ylä-Herttuala, Matti Korhonen, Kim Vettenranta, Anita Laitinen, Urpu Salmenniemi, Erja Kerkelä
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Nature Portfolio 2024-11-01
Schriftenreihe:	Scientific Reports
Schlagworte:	Immunotherapy Natural killer cells AML blast CliniMACS prodigy
Online-Zugang:	https://doi.org/10.1038/s41598-024-76791-2
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!